The fate of small-size pericardial heart valve prostheses in an older patient population Ruggero De Paulis, MD, Salvatore D'Aleo, MD, Alessandro Bellisario, MD, Andrea Salica, MD, Luca P. Weltert, MD, Raffaele Scaffa, MD, Lorenzo Guerrieri Wolf, MD, Daniele Maselli, MD, Michele Di Mauro, MD The Journal of Thoracic and Cardiovascular Surgery Volume 153, Issue 1, Pages 31-39.e2 (January 2017) DOI: 10.1016/j.jtcvs.2016.08.063 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Mean transprosthetic gradient average values and outliers in longitudinal echocardiography surveillance. *P < .05 versus discharge. The Journal of Thoracic and Cardiovascular Surgery 2017 153, 31-39.e2DOI: (10.1016/j.jtcvs.2016.08.063) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Overall survival and patients at risk in the whole patient population divided by size 19- or 21-mm Mitroflow valve prostheses (LivaNova, London, United Kingdom). The Journal of Thoracic and Cardiovascular Surgery 2017 153, 31-39.e2DOI: (10.1016/j.jtcvs.2016.08.063) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure 3 Cardiac- and valve-related mortality and patients at risk, for the operative survivors. The Journal of Thoracic and Cardiovascular Surgery 2017 153, 31-39.e2DOI: (10.1016/j.jtcvs.2016.08.063) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure 4 Freedom from reoperation because of structural valve deterioration (SVD) and patients at risk, for the operative survivors. AVR, Aortic valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2017 153, 31-39.e2DOI: (10.1016/j.jtcvs.2016.08.063) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure 5 Freedom from structural valve deterioration (SVD) (as defined by a mean gradient > 35 mm Hg) and patients at risk, for the operative survivors. The Journal of Thoracic and Cardiovascular Surgery 2017 153, 31-39.e2DOI: (10.1016/j.jtcvs.2016.08.063) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure 6 Freedom from structural valve deterioration (SVD) (as defined by a mean gradient >35 mm Hg) and patients at risk, for the operative survivors, divided by the 2 sizes of implanted Mitroflow valve prostheses (LivaNova, London, United Kingdom). The Journal of Thoracic and Cardiovascular Surgery 2017 153, 31-39.e2DOI: (10.1016/j.jtcvs.2016.08.063) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure E1 Nomogram of time from implant expected freedom from structural valve deterioration (SVD) stratified by age-class. The Journal of Thoracic and Cardiovascular Surgery 2017 153, 31-39.e2DOI: (10.1016/j.jtcvs.2016.08.063) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Freedom from structural valve deterioration in 19- and 21-mm Mitroflow valve prostheses (LivaNova, London, United Kingdom). The Journal of Thoracic and Cardiovascular Surgery 2017 153, 31-39.e2DOI: (10.1016/j.jtcvs.2016.08.063) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions